Economic burden of cardiomyopathy in Canada 2018 to 2021: opportunity for cost avoidance through pharmaceutical innovation. Brett J Skinner, PhD ABSTRACT This study estimated the economic illness associated with (CM), by hospital cost, productivity loss,

BACKGROUND Given current neglect for Chagas disease in public health programs in Mexico, future healthcare and economic development policies will need a more robust model to analyze costs and impacts of timely clinical attention of infected populations. METHODOLOGY/PRINCIPAL FINDINGS A Markov decision model was constructed to simulate the natural history of a Chagas disease cohort in Mexico a...